| Drug General Information |
| Drug ID |
D0C3WY
|
| Former ID |
DNC006196
|
| Drug Name |
3,4-diphenyl-1H-pyrrole-2,5-dione
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C16H11NO2
|
| Canonical SMILES |
C1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=CC=C3
|
| InChI |
1S/C16H11NO2/c18-15-13(11-7-3-1-4-8-11)14(16(19)17-15)12-9-5-2-6-10-12/h1-10H,(H,17,18,19)
|
| InChIKey |
WADCPEMKIBAJHH-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
Protein kinase C, epsilon type |
Target Info |
Inhibitor |
[1]
|
|---|
| mRNA of HER2 |
Target Info |
Inhibitor |
[1]
|
| Cell division protein kinase 2 |
Target Info |
Inhibitor |
[1]
|
| Epidermal growth factor receptor |
Target Info |
Inhibitor |
[1]
|
| G2/mitotic-specific cyclin B1 |
Target Info |
Inhibitor |
[1]
|
| Vascular endothelial growth factor receptor 2 |
Target Info |
Inhibitor |
[1]
|
| Cell division protein kinase 4 |
Target Info |
Inhibitor |
[1]
|
| Protein kinase C, alpha type |
Target Info |
Inhibitor |
[1]
|
| Angiopoietin 1 receptor |
Target Info |
Inhibitor |
[1]
|
| Cell division control protein 2 homolog |
Target Info |
Inhibitor |
[1]
|
| Cell division protein kinase 6 |
Target Info |
Inhibitor |
[1]
|
| G1/S-specific cyclin E1 |
Target Info |
Inhibitor |
[1]
|
| G1/S-specific cyclin D1 |
Target Info |
Inhibitor |
[1]
|
| Protein kinase C gamma type |
Target Info |
Inhibitor |
[1]
|
|
KEGG Pathway
|
cGMP-PKG signaling pathway
|
|
Sphingolipid signaling pathway
|
|
Vascular smooth muscle contraction
|
|
Tight junction
|
|
Fc epsilon RI signaling pathway
|
|
Fc gamma R-mediated phagocytosis
|
|
Inflammatory mediator regulation of TRP channels
|
|
Type II diabetes mellitus
|
|
MicroRNAs in cancerhsa04012:ErbB signaling pathway
|
|
Calcium signaling pathway
|
|
HIF-1 signaling pathway
|
|
Focal adhesion
|
|
Adherens junction
|
|
Pathways in cancer
|
|
Proteoglycans in cancer
|
|
MicroRNAs in cancer
|
|
Pancreatic cancer
|
|
Endometrial cancer
|
|
Prostate cancer
|
|
Bladder cancer
|
|
Non-small cell lung cancer
|
|
Central carbon metabolism in cancerhsa04068:FoxO signaling pathway
|
|
Cell cycle
|
|
Oocyte meiosis
|
|
p53 signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
Progesterone-mediated oocyte maturation
|
|
Hepatitis B
|
|
Measles
|
|
Herpes simplex infection
|
|
Epstein-Barr virus infection
|
|
Viral carcinogenesis
|
|
Small cell lung cancerhsa04010:MAPK signaling pathway
|
|
ErbB signaling pathway
|
|
Ras signaling pathway
|
|
Rap1 signaling pathway
|
|
Cytokine-cytokine receptor interaction
|
|
FoxO signaling pathway
|
|
Endocytosis
|
|
Dorso-ventral axis formation
|
|
Gap junction
|
|
Regulation of actin cytoskeleton
|
|
GnRH signaling pathway
|
|
Estrogen signaling pathway
|
|
Oxytocin signaling pathway
|
|
Epithelial cell signaling in Helicobacter pylori infection
|
|
Hepatitis C
|
|
Glioma
|
|
Melanoma
|
|
Central carbon metabolism in cancer
|
|
Choline metabolism in cancerhsa04068:FoxO signaling pathway
|
|
Progesterone-mediated oocyte maturationhsa04014:Ras signaling pathway
|
|
VEGF signaling pathway
|
|
Proteoglycans in cancerhsa04110:Cell cycle
|
|
T cell receptor signaling pathway
|
|
HTLV-I infection
|
|
Chronic myeloid leukemia
|
|
Small cell lung cancer
|
|
Non-small cell lung cancerhsa04010:MAPK signaling pathway
|
|
Phosphatidylinositol signaling system
|
|
mTOR signaling pathway
|
|
Adrenergic signaling in cardiomyocytes
|
|
Wnt signaling pathway
|
|
Natural killer cell mediated cytotoxicity
|
|
Leukocyte transendothelial migration
|
|
Circadian entrainment
|
|
Long-term potentiation
|
|
Retrograde endocannabinoid signaling
|
|
Glutamatergic synapse
|
|
Cholinergic synapse
|
|
Serotonergic synapse
|
|
GABAergic synapse
|
|
Dopaminergic synapse
|
|
Long-term depression
|
|
Insulin secretion
|
|
Melanogenesis
|
|
Thyroid hormone synthesis
|
|
Thyroid hormone signaling pathway
|
|
Aldosterone-regulated sodium reabsorption
|
|
Endocrine and other factor-regulated calcium reabsorption
|
|
Salivary secretion
|
|
Gastric acid secretion
|
|
Pancreatic secretion
|
|
Amphetamine addiction
|
|
Morphine addiction
|
|
Vibrio cholerae infection
|
|
Pathogenic Escherichia coli infection
|
|
African trypanosomiasis
|
|
Amoebiasis
|
|
Influenza A
|
|
Choline metabolism in cancerhsa04014:Ras signaling pathway
|
|
Rheumatoid arthritishsa04110:Cell cycle
|
|
Viral carcinogenesishsa04110:Cell cycle
|
|
Non-small cell lung cancerhsa04110:Cell cycle
|
|
Small cell lung cancerhsa04068:FoxO signaling pathway
|
|
AMPK signaling pathway
|
|
Hippo signaling pathway
|
|
Jak-STAT signaling pathway
|
|
Prolactin signaling pathway
|
|
Colorectal cancer
|
|
Thyroid cancer
|
|
Acute myeloid leukemia
|
|
Viral myocarditishsa04010:MAPK signaling pathway
|
|
Choline metabolism in cancer
|
|
NetPath Pathway
|
IL2 Signaling PathwayNetPath_11:TCR Signaling PathwayNetPath_11:TCR Signaling PathwayNetPath_16:IL4 Signaling Pathway
|
|
EGFR1 Signaling PathwayNetPath_11:TCR Signaling PathwayNetPath_14:IL2 Signaling PathwayNetPath_11:TCR Signaling Pathway
|
|
EGFR1 Signaling Pathway
|
|
RANKL Signaling PathwayNetPath_14:IL2 Signaling PathwayNetPath_8:Wnt Signaling PathwayNetPath_21:RANKL Signaling PathwayNetPath_7:TGF_beta_Receptor Signaling PathwayNetPath_14:IL2 Signaling Pathway
|
|
TCR Signaling PathwayNetPath_11:TCR Signaling Pathway
|
|
IL2 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
Notch Signaling Pathway
|
|
Wnt Signaling Pathway
|
|
PANTHER Pathway
|
Alpha adrenergic receptor signaling pathway
|
|
Alzheimer disease-amyloid secretase pathway
|
|
Angiogenesis
|
|
Apoptosis signaling pathway
|
|
EGF receptor signaling pathway
|
|
Endothelin signaling pathway
|
|
FGF signaling pathway
|
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
|
Inflammation mediated by chemokine and cytokine signaling pathway
|
|
Muscarinic acetylcholine receptor 1 and 3 signaling pathway
|
|
VEGF signaling pathway
|
|
Wnt signaling pathway
|
|
5HT2 type receptor mediated signaling pathway
|
|
Histamine H1 receptor mediated signaling pathway
|
|
Oxytocin receptor mediated signaling pathway
|
|
Thyrotropin-releasing hormone receptor signaling pathway
|
|
CCKR signaling map STP00012:Cadherin signaling pathway
|
|
EGF receptor signaling pathwayP00059:p53 pathway
|
|
p53 pathway feedback loops 2P00012:Cadherin signaling pathway
|
|
EGF receptor signaling pathwayP00059:p53 pathwayP00005:Angiogenesis
|
|
VEGF signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
|
|
PDGF signaling pathway
|
|
Angiotensin II-stimulated signaling through G proteins and beta-arrestin
|
|
CCKR signaling map STP00005:AngiogenesisP00013:Cell cycle
|
|
Parkinson disease
|
|
p53 pathway
|
|
p53 pathway feedback loops 2P00048:PI3 kinase pathway
|
|
CCKR signaling map STP00002:Alpha adrenergic receptor signaling pathway
|
|
Pathway Interaction Database
|
Endothelins
|
|
LPA receptor mediated events
|
|
TCR signaling in naï
|
|
LPA4-mediated signaling events
|
|
CDC42 signaling events
|
|
TCR signaling in naï
|
|
Thromboxane A2 receptor signaling
|
|
Role of Calcineurin-dependent NFAT signaling in lymphocytes
|
|
IL2-mediated signaling events
|
|
PDGFR-beta signaling pathway
|
|
IL8- and CXCR1-mediated signaling events
|
|
Regulation of Ras family activation
|
|
Downstream signaling in naï
|
|
ErbB4 signaling events
|
|
ErbB2/ErbB3 signaling events
|
|
ErbB receptor signaling network
|
|
a6b1 and a6b4 Integrin signaling
|
|
Validated targets of C-MYC transcriptional repressionsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
|
|
Signaling events mediated by PRL
|
|
p73 transcription factor network
|
|
E2F transcription factor network
|
|
ATR signaling pathway
|
|
mTOR signaling pathway
|
|
FoxO family signaling
|
|
FOXM1 transcription factor network
|
|
BARD1 signaling events
|
|
p53 pathway
|
|
Regulation of retinoblastoma proteinlysophospholipid_pathway:LPA receptor mediated events
|
|
Signaling events mediated by PTP1B
|
|
Arf6 signaling events
|
|
Signaling events mediated by TCPTP
|
|
SHP2 signaling
|
|
Regulation of Telomerase
|
|
EGF receptor (ErbB1) signaling pathway
|
|
EGFR-dependent Endothelin signaling events
|
|
Posttranslational regulation of adherens junction stability and dissassembly
|
|
Direct p53 effectors
|
|
ErbB1 downstream signaling
|
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
E-cadherin signaling in keratinocytes
|
|
Internalization of ErbB1
|
|
Stabilization and expansion of the E-cadherin adherens junction
|
|
Syndecan-3-mediated signaling eventsp73pathway:p73 transcription factor network
|
|
Validated targets of C-MYC transcriptional activation
|
|
PLK1 signaling events
|
|
C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network
|
|
Beta3 integrin cell surface interactions
|
|
S1P1 pathway
|
|
VEGF and VEGFR signaling network
|
|
Integrins in angiogenesis
|
|
Signaling events mediated by VEGFR1 and VEGFR2
|
|
Notch-mediated HES/HEY networksmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
|
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
|
ATF-2 transcription factor network
|
|
Regulation of retinoblastoma proteinendothelinpathway:Endothelins
|
|
Canonical NF-kappaB pathway
|
|
Signaling events regulated by Ret tyrosine kinase
|
|
Ras signaling in the CD4+ TCR pathway
|
|
Syndecan-4-mediated signaling events
|
|
Retinoic acid receptors-mediated signaling
|
|
IL8- and CXCR2-mediated signaling events
|
|
VEGFR1 specific signals
|
|
PAR1-mediated thrombin signaling events
|
|
Angiopoietin receptor Tie2-mediated signaling
|
|
SHP2 signalingp73pathway:p73 transcription factor network
|
|
AP-1 transcription factor network
|
|
Retinoic acid receptors-mediated signalingp73pathway:p73 transcription factor network
|
|
Coregulation of Androgen receptor activity
|
|
C-MYB transcription factor network
|
|
IL2 signaling events mediated by STAT5
|
|
Regulation of retinoblastoma proteinprlsignalingeventspathway:Signaling events mediated by PRL
|
|
PLK3 signaling events
|
|
Regulation of retinoblastoma proteinnotch_pathway:Notch signaling pathway
|
|
Validated transcriptional targets of AP1 family members Fra1 and Fra2
|
|
Presenilin action in Notch and Wnt signaling
|
|
Integrin-linked kinase signaling
|
|
E-cadherin signaling in the nascent adherens junction
|
|
Neurotrophic factor-mediated Trk receptor signaling
|
|
Validated nuclear estrogen receptor alpha network
|
|
Signaling mediated by p38-gamma and p38-delta
|
|
Regulation of nuclear beta catenin signaling and target gene transcription
|
|
Validated targets of C-MYC transcriptional repression
|
|
Trk receptor signaling mediated by PI3K and PLC-gamma
|
|
Regulation of retinoblastoma protein
|
|
Signaling events mediated by focal adhesion kinaseendothelinpathway:Endothelins
|
|
PathWhiz Pathway
|
Phosphatidylinositol Phosphate MetabolismPW000453:Fc Epsilon Receptor I Signaling in Mast Cells
|
|
Activation of PKC through G protein coupled receptor
|
|
Reactome
|
Effects of PIP2 hydrolysis
|
|
DAG and IP3 signaling
|
|
Role of phospholipids in phagocytosis
|
|
G alpha (z) signalling eventsR-HSA-1250196:SHC1 events in ERBB2 signaling
|
|
PLCG1 events in ERBB2 signaling
|
|
PIP3 activates AKT signaling
|
|
GRB2 events in ERBB2 signaling
|
|
PI3K events in ERBB2 signaling
|
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
|
Sema4D induced cell migration and growth-cone collapse
|
|
RAF/MAP kinase cascadeR-HSA-1538133:G0 and Early G1
|
|
Activation of ATR in response to replication stress
|
|
Regulation of APC/C activators between G1/S and early anaphase
|
|
SCF(Skp2)-mediated degradation of p27/p21
|
|
Senescence-Associated Secretory Phenotype (SASP)
|
|
DNA Damage/Telomere Stress Induced Senescence
|
|
Processing of DNA double-strand break ends
|
|
G2 Phase
|
|
Orc1 removal from chromatin
|
|
Cyclin E associated events during G1/S transition
|
|
Cyclin A/B1 associated events during G2/M transition
|
|
p53-Dependent G1 DNA Damage Response
|
|
Cyclin A:Cdk2-associated events at S phase entry
|
|
Meiotic recombination
|
|
Factors involved in megakaryocyte development and platelet productionR-HSA-1236382:Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
|
|
SHC1 events in ERBB2 signaling
|
|
GRB2 events in EGFR signaling
|
|
GAB1 signalosome
|
|
SHC1 events in EGFR signaling
|
|
EGFR downregulation
|
|
EGFR Transactivation by Gastrin
|
|
Constitutive Signaling by EGFRvIII
|
|
RAF/MAP kinase cascadeR-HSA-156711:Polo-like kinase mediated events
|
|
Golgi Cisternae Pericentriolar Stack Reorganization
|
|
Phosphorylation of the APC/C
|
|
Phosphorylation of Emi1
|
|
Condensation of Prophase Chromosomes
|
|
MASTL Facilitates Mitotic Progression
|
|
Resolution of Sister Chromatid Cohesion
|
|
Condensation of Prometaphase Chromosomes
|
|
Regulation of PLK1 Activity at G2/M Transition
|
|
Activation of NIMA Kinases NEK9, NEK6, NEK7
|
|
Recruitment of NuMA to mitotic centrosomes
|
|
Depolymerisation of the Nuclear Lamina
|
|
G2/M DNA replication checkpoint
|
|
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complexR-HSA-194306:Neurophilin interactions with VEGF and VEGFR
|
|
VEGF binds to VEGFR leading to receptor dimerization
|
|
Integrin cell surface interactions
|
|
EPHA-mediated growth cone collapse
|
|
VEGFA-VEGFR2 Pathway
|
|
VEGFR2 mediated cell proliferationR-HSA-2559580:Oxidative Stress Induced Senescence
|
|
Oncogene Induced Senescence
|
|
RMTs methylate histone arginines
|
|
Transcriptional regulation of white adipocyte differentiation
|
|
Ubiquitin-dependent degradation of Cyclin D1
|
|
Cyclin D associated events in G1
|
|
Meiotic recombinationR-HSA-111933:Calmodulin induced events
|
|
Disinhibition of SNARE formation
|
|
Regulation of KIT signaling
|
|
Inactivation, recovery and regulation of the phototransduction cascade
|
|
Syndecan interactions
|
|
Acetylcholine regulates insulin secretion
|
|
Ca2+ pathway
|
|
Trafficking of GluR2-containing AMPA receptors
|
|
G alpha (z) signalling events
|
|
HuR (ELAVL1) binds and stabilizes mRNA
|
|
WNT5A-dependent internalization of FZD4
|
|
VEGFR2 mediated cell proliferation
|
|
Response to elevated platelet cytosolic Ca2+R-HSA-210993:Tie2 Signaling
|
|
RAF/MAP kinase cascadeR-HSA-110056:MAPK3 (ERK1) activation
|
|
E2F mediated regulation of DNA replication
|
|
G0 and Early G1
|
|
Cyclin B2 mediated events
|
|
Cdc20:Phospho-APC/C mediated degradation of Cyclin A
|
|
Loss of Nlp from mitotic centrosomes
|
|
Recruitment of mitotic centrosome proteins and complexes
|
|
Loss of proteins required for interphase microtubule organization?from the centrosome
|
|
Anchoring of the basal body to the plasma membrane
|
|
MAPK6/MAPK4 signaling
|
|
G1/S-Specific Transcription
|
|
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complexR-HSA-2559580:Oxidative Stress Induced Senescence
|
|
Cyclin D associated events in G1R-HSA-113510:E2F mediated regulation of DNA replication
|
|
p53-Dependent G1 DNA Damage ResponseR-HSA-1912408:Pre-NOTCH Transcription and Translation
|
|
Cyclin D associated events in G1R-HSA-111933:Calmodulin induced events
|
|
Response to elevated platelet cytosolic Ca2+
|
|
WikiPathways
|
Hypothetical Network for Drug Addiction
|
|
Calcium Regulation in the Cardiac Cell
|
|
Wnt Signaling Pathway
|
|
Wnt Signaling Pathway and Pluripotency
|
|
G Protein Signaling Pathways
|
|
Myometrial Relaxation and Contraction Pathways
|
|
Oncostatin M Signaling Pathway
|
|
miRs in Muscle Cell Differentiation
|
|
GPCR downstream signaling
|
|
Effects of PIP2 hydrolysis
|
|
Physiological and Pathological Hypertrophy of the HeartWP710:DNA Damage Response (only ATM dependent)
|
|
ErbB Signaling Pathway
|
|
EGF/EGFR Signaling Pathway
|
|
Extracellular vesicle-mediated signaling in recipient cells
|
|
Bladder Cancer
|
|
Signaling by ERBB2
|
|
Integrated Pancreatic Cancer Pathway
|
|
Signaling Pathways in Glioblastoma
|
|
Leptin signaling pathway
|
|
miR-targeted genes in muscle cell - TarBase
|
|
Semaphorin interactionsWP707:DNA Damage Response
|
|
ID signaling pathway
|
|
DNA Replication
|
|
G1 to S cell cycle control
|
|
M/G1 Transition
|
|
S Phase
|
|
Meiotic Recombination
|
|
Aryl Hydrocarbon Receptor
|
|
ATM Signaling Pathway
|
|
Retinoblastoma (RB) in Cancer
|
|
Spinal Cord Injury
|
|
Prostate Cancer
|
|
TSH signaling pathway
|
|
Integrated Breast Cancer Pathway
|
|
Integrated Cancer pathway
|
|
Synthesis of DNA
|
|
Regulation of DNA replication
|
|
Mitotic G2-G2/M phases
|
|
Mitotic G1-G1/S phases
|
|
Factors involved in megakaryocyte development and platelet production
|
|
Cell Cycle
|
|
APC/C-mediated degradation of cell cycle proteins
|
|
Cell Cycle Checkpoints
|
|
miRNA Regulation of DNA Damage ResponseWP673:ErbB Signaling Pathway
|
|
Regulation of Actin Cytoskeleton
|
|
MAPK Signaling Pathway
|
|
Focal Adhesion
|
|
Aryl Hydrocarbon Receptor Pathway
|
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
|
|
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
|
|
Hair Follicle Development: Induction (Part 1 of 3)
|
|
Signaling by ERBB4
|
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
|
PIP3 activates AKT signaling
|
|
Nanoparticle-mediated activation of receptor signaling
|
|
Gastric cancer network 2
|
|
AGE/RAGE pathway
|
|
Arylhydrocarbon receptor (AhR) signaling pathway
|
|
miR-targeted genes in lymphocytes - TarBase
|
|
miR-targeted genes in epithelium - TarBase
|
|
Signaling by EGFR
|
|
L1CAM interactionsWP707:DNA Damage Response
|
|
Mitotic Prophase
|
|
Mitotic Prometaphase
|
|
miRNA Regulation of DNA Damage Response
|
|
AMPK SignalingWP306:Focal Adhesion
|
|
Nifedipine Activity
|
|
Cardiac Progenitor Differentiation
|
|
Signaling by VEGF
|
|
AngiogenesisWP707:DNA Damage Response
|
|
Ovarian Infertility Genes
|
|
PPAR Alpha Pathway
|
|
Transcriptional Regulation of White Adipocyte Differentiation
|
|
Insulin Signaling
|
|
Wnt Signaling Pathway Netpath
|
|
Kit receptor signaling pathway
|
|
Transcriptional activation by NRF2
|
|
Human Complement System
|
|
Cardiac Hypertrophic Response
|
|
Syndecan interactions
|
|
Regulation of mRNA Stability by Proteins that Bind AU-rich Elements
|
|
Signaling by SCF-KIT
|
|
DAG and IP3 signaling
|
|
T-Cell Receptor and Co-stimulatory Signaling
|
|
Alpha 6 Beta 4 signaling pathway
|
|
Corticotropin-releasing hormone
|
|
Pathogenic Escherichia coli infection
|
|
Endothelin Pathways
|
|
Regulation of Microtubule Cytoskeleton
|
|
FSH signaling pathway
|
|
Opioid Signalling
|
|
Response to elevated platelet cytosolic Ca2+
|
|
Integration of energy metabolism
|
|
TOR SignalingWP363:Wnt Signaling Pathway Netpath
|
|
Cell surface interactions at the vascular wall
|
|
TGF beta Signaling Pathway
|
|
MAP kinase activation in TLR cascade
|
|
RAF/MAP kinase cascade
|
|
BMI1
|
|
miRNA Regulation of DNA Damage ResponseWP707:DNA Damage Response
|
|
Metastatic brain tumor
|
|
miR-targeted genes in leukocytes - TarBase
|
|
miRNAs involved in DNA damage response
|
|
Parkinsons Disease Pathway
|
|
Parkin-Ubiquitin Proteasomal System pathway
|
|
Androgen receptor signaling pathwayWP710:DNA Damage Response (only ATM dependent)
|
|
DNA Damage Response
|
|
Notch Signaling Pathway
|
|
Copper homeostasis
|
|
Mesodermal Commitment Pathway
|
|
Hair Follicle Development: Organogenesis (Part 2 of 3)
|
|
Pre-NOTCH Expression and Processing
|
|
Polycystic Kidney Disease Pathway
|
|
IL-7 Signaling Pathway
|
|
Androgen receptor signaling pathwayWP536:Calcium Regulation in the Cardiac Cell
|
| References |
| REF 1 | J Med Chem. 2006 Feb 23;49(4):1271-81.Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors. |
|---|
